Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease

Abstract

Objective. The percentage measurement of hypochromic red cells (HYPO) and reticulocyte haemoglobin content (CHr) using the ADVIA system has recently been validated as a useful tool in indicating iron deficiency, also in cases of chronic diseases such as renal failure. The aim of this study was to evaluate the extent to which the red cell parameters, RBC‐Y and RET‐Y, provided by Sysmex XE 2100, correlate with HYPO and CHr. Material and methods. The laboratory markers of iron status were evaluated together with HYPO, CHr, RBC‐Y and RET‐Y in 92 healthy subjects (C), 42 iron‐deficient patients (ID) and 88 uraemic patients receiving regular dialysis treatment (RDT). Results. In ID patients, increased HYPO and decreased RBC‐Y, CHr and RET‐Y values, with no overlapping with reference values, were found and a significant correlation was present between ADVIA 120 and Sysmex indices (p<0.001 for each correlation). In RDT patients, HYPO median values were increased with a wide distribution of values (95 % reference range = 0.7–27.5 % and 0.7–22.6 % in men and women, respectively). In contrast, RBC‐Y was normal/increased (95 % reference range = 169.4–191.1 and 168.7–190.5 in men and women, respectively), even though there was a significant correlation between them (p<0.001). CHr and RET‐Y values were within the reference range; moreover, in these patients mean cell volume of red cells and of reticulocytes (MCV and MCVr) median values were increased. Conclusions. This study confirmed the validity of RBC‐Y in the management of ID, but not in RDT, where the diagnostic power of RBC‐Y as an index of cell hypochromia is limited owing to high MCV values.

• Anaemia
• hypochromic‐cell percentage (HYPO)
• recombinant human erythropoietin (r‐HuEPO)
• regular dialysis treatment (RDT)
• reticulocyte
• reticulocyte haemoglobin content (CHr)